Clinical Trial Update: Cangrelor in ST-Elevation Myocardial Infarction to Decrease Infarct Size [Phase 4]

View source ↗

Summary

Phase 4 trial update on cangrelor for reducing infarct size in ST-elevation myocardial infarction; study terminated with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• Cangrelor (cangrelor)

Snippet

Sponsor: Khaled Ziada, MD | Conditions: STEMI - ST Elevation Myocardial Infarction | Phase 4 | Status: TERMINATED | Results posted: 2020-06-30